Comparative Evaluation of EGF in Oral Lichen Planus and Oral Squamous Cell Carcinoma
-
Farzaneh Agha-Hosseini
,
Mina Mohebbian
,
Mohammad-Reza Sarookani
,
Iraj Harirchi
,
Iraj Mirzaii-Dizgah
Abstract
Oral lichen planus (OLP) is classified as a potential malignant disorder, and epidermal growth factor (EGF) may play a key role in cancer development. The aim of this study was to compare serum and saliva EGF among patients with OLP and oral squamous cell carcinoma (OSCC). A cross-sectional study was performed on 27 patients with OLP (10 reticular and 17 atrophic-erosive forms), 27 patients with OSCC and 27 healthy control group. The study was conducted at the Cancer Department, Clinic of Oral Medicine, Tehran University of Medical Sciences. The serum and saliva EGF were assayed by ELISA method. Statistical analysis of ANOVA was used. The mean serum EGF in OLP and OSCC patients was significantly lower compared to healthy control group (P < 0.05), but no significant difference was observed between OLP and OSCC patients. There was no significant difference in mean salivary EGF among groups. As serum EGF levels appear to be statistically similar in OLP and OSCC, it seems that EGF might play a role in the pathogenesis of OLP and its cancerization.
Ebrahimi M, Boldrup L, Wahlin YB, et al. Decreased expression of the p63 related proteins beta-catenin, Ecadherin and EGFR in oral lichen planus. Oral Oncol 2008;44(7):634-8.
Tao X, Huang Y, Li R, et al. Assessment of local angiogenesis and vascular endothelial growth factor in the patients with atrophic-erosive and reticular oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(5):661-9.
Scardina GA, Ruggieri A, Maresi E, et al. Angiogenesis in oral lichen planus: an in vivo and immunohistological evaluation. Arch Immunol Ther Exp (Warsz) 2011;59(6):457-62.
Aghahosseini F, Arbabi-Kalati F, Fashtami LA, et al. Methylene blue-mediated photodynamic therapy: a possible alternative treatment for oral lichen planus. Lasers Surg Med 2006;38(1):33-8.
Aghahosseini F, Arbabi-Kalati F, Fashtami LA, et al. Treatment of oral lichen planus with photodynamic therapy mediated methylene blue: a case report. Medicina oral, Patologia Oral y Cirugia Bucal 2006;11(2):E126-9.
Agha-Hosseini F, Mirzaii-Dizgah I, Abdollahi M, et al. Efficacy of IMOD in the treatment of oral lichen planus. Open J Stomatol 2011;1(1):13-7.
Agha-Hosseini F, Moslemi E, Mirzaii-Dizgah I. Comparative evaluation of low-level laser and CO₂ laser in treatment of patients with oral lichen planus. Int J Oral Maxillofac Surg 2012;41(10):1265-9.
Kumagai K, Horikawa T, Gotoh A, et al. Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(6):748-54.
Cheng SJ, Lee JJ, Kok SH, et al. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan. J Formos Med Assoc 2011;110(1):50-7.
Agha-Hosseini F, Mirzaii-Dizgah I, Farmanbar N, et al. Oxidative stress status and DNA damage in the saliva of human subjects with oral lichen planus and oral squamous cell carcinoma. J Oral Pathol Med 2012;41(10):736-40.
Okada F, Fujii J. Oxidative stress-induced carcinogenesis and its prevention. J Clin Biochem Nutr 2006;39(3):103-13.
Bernardes VF, Gleber-Netto FO, Sousa SF, et al. EGF in saliva and tumor samples of oral squamous cell carcinoma. Appl Immunohistochem Mol Morphol 2011;19(6):528-33.
Pezelj-Ribaric S, Prso IB, Abram M, et al. Salivary levels of tumor necrosis factor-alpha in oral lichen planus. Mediators Inflamm 2004;13(2):131-3.
Agha-Hosseini F, Khalili M, Rohani B. Immunohistochemistry analysis of P53 and Ki-67 proteins in oral lichen planus and normal oral mucosa. Iran J Publ Health 2009;38(2):37-43.
Agha-Hosseini F, Mirzaii-Dizgah I, Mikaili S, et al. Increased salivary lipid peroxidation in human subjects with oral lichen planus. Int J Dent Hyg 2009;7(4):246-50.
Balicki R, Grabowska SZ, Citko A. Salivary epidermal growth factor in oral cavity cancer. Oral Oncol 2005;41(1):48-55.
Dai W, Li Y, Zhou Q, et al. Cetuximab inhibits oral squamous cell carcinoma invasion and metastasis via degradation of epidermal growth factor receptor. J Oral Pathol Med 2014;43(4):250-7.
Ino M, Ushiro K, Ino C, et al. Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl 1993;500: 126-30.
Dumbrigue HB, Sandow PL, Nguyen KH, et al. Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;89(6):710-6.
Shpitzer T, Bahar G, Feinmesser R, et al. A comprehensive salivary analysis for oral cancer diagnosis. J Cancer Res Clin Oncol 2007;133(9):613-7.
| Files | ||
| Issue | Vol 53, No 8 (2015) | |
| Section | Original Article(s) | |
| Keywords | ||
| EGF Oral lichen planus Squamous cell carcinoma Saliva | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
